Navigation Links
Onda Reaches Distribution Agreement with S&V Korea to Expand Presence in South Korea
Date:4/28/2011

SUNNYVALE, Calif., April 28, 2011 /PRNewswire/ -- Onda Corporation, the leading global provider of ultrasound measurement instrumentation, announced an agreement with S&V Korea for distribution of its products to the government and academic sector in South Korea. S&V Korea is a leading distributor providing sound and vibration solutions to a wide range of industries.

"With the continued growth in South Korea, a strategic partnership with a respected local distributor offers the reassurance that our quality of support for our customers will be maintained at the highest level," said Petrie Yam, V.P. of Sales and Marketing. "Partnering with S&V Korea is a natural fit. They have established a strong network within the South Korean government and academic sector, and we look forward to elevating our engagement with our customers."

S&V Korea founder and managing director, Mr. S.I. Choi, comments, "We are excited to partner with Onda. They have established themselves as the gold standard in ultrasound measurement solutions within the Korean medical community. The R&D and regulatory requirements in ultrasound continue to become more stringent in South Korea, and this new relationship will connect our customers with Onda's broad range of products and services."

About Onda:

Onda Corporation is the global leader in ultrasound measurement instrumentation and services. Their products are used to characterize acoustic intensity and power in the medical ultrasonic and industrial megasonic fields. Onda also offers services to design, develop, and manufacture the most complex medical devices for therapeutic, diagnostic, and physiotherapy applications.

About S&V Korea:

S&V Korea is a leading distributor representing a number of precision test instrumentation companies in South Korea for a wide range of applications including non-destructive testing, medical, and general academic research.

For more information: visit http://www.ondacorp.com and http://www.snvkorea.co.kr

Contact: Ms. Madie Chua
Onda Corporation
Phone: (408) 745-0383
info@ondacorp.com
http://www.ondacorp.com

This press release was issued through eReleases(R).  For more information, visit eReleases Press Release Distribution at http://www.ereleases.com.


'/>"/>
SOURCE Onda Corporation
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Enrollment Reaches 110 Patients in Investigator Initiated, Randomized Trial of OrbusNeichs Genous(TM) Bio-Engineered R Stent(TM)
2. Arizona Heart Hospital Reaches Settlement Regarding Clinical Research Matter
3. CSL Behring Reaches Primary Endpoint in Clinical Study of C1-INH for Treatment of Hereditary Angioedema
4. Cancer Pioneer Reaches Key Agreement on Colon Cancer Drug OncoVAX(R)
5. CureHIV Reaches Out to Bill and Melinda Gates to Fund LiSAVIOR
6. Genmab Reaches Milestone in Ofatumumab Collaboration
7. Neurobiological Technologies Reaches Patient Enrollment Target For Interim Analysis of Viprinex(TM) Phase 3 Stroke Trials
8. AEterna Zentaris Reaches 2nd Stage of Patient Recruitment for Phase 2 Trial in Ovarian Cancer with the Innovative LHRH Receptor Targeted Conjugate, AEZS-108
9. Catalyst Reaches Enrollment Target for its U.S. Phase II Cocaine Trial
10. R&D Spending by U.S. Biopharmaceutical Companies Reaches Record Levels in 2008 Despite Economic Challenges
11. Terumo Heart, Inc. Reaches Clinical Milestone as the 100th Patient Worldwide Receives the DuraHeart(TM) Left Ventricular Assist System
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/23/2017)... The top three players dominating ... Koninklijke Philips N.V., and Schiller. Collectively, these companies held ... in 2015. Strong product portfolio and a monumental geographical ... aiding these players remain leaders in the fragmented competitive ... the global market are likely to focus on mergers ...
(Date:2/23/2017)... February 23, 2017 Tillotts Pharma ... Berlin office was opened in ... . The portfolio includes Entocort ® for the ... treatment of ulcerative colitis, and VistaPrep ® for ... Swiss specialty pharmaceutical company focused on the treatment of ...
(Date:2/23/2017)... and VANCOUVER, British Columbia , ... OGXI ) today announced its year end 2016 ... In January 2017, OncoGenex, and Achieve Life Science, Inc., ... have entered into a definitive merger agreement under which ... completion of the proposed merger, Achieve,s stockholders are expected ...
Breaking Medicine Technology:
(Date:2/23/2017)... ... February 23, 2017 , ... Rare Disease ... will be participating in Rare Disease Day events, hosted by the Rare Disease ... Disease Report, a website, weekly e-newsletter and quarterly publication, will be conducting interviews ...
(Date:2/23/2017)... ... February 23, 2017 , ... EBSCO Information ... National Institute for Health and Care Excellence (NICE) framework. The agreement ... Health Service (NHS) to search, order and purchase medical and healthcare-related content through ...
(Date:2/23/2017)... ... 23, 2017 , ... Current Meditation , a new ... throughout the U.S. starting this spring. Current Meditation focuses on “meditation for the ... Current Meditation will be the first meditation concept in the U.S. offering franchising ...
(Date:2/23/2017)... CA (PRWEB) , ... February 23, 2017 , ... Top ... Smiling Patriot program today with a new Indiegogo campaign . Individuals ... to homeless veterans in the Los Angeles area, either as a participating patient or ...
(Date:2/22/2017)... New York (PRWEB) , ... February 22, 2017 ... ... floor entrance and lobby of a new healthcare contact center in Georgia, PENETRON ... , One of the nation’s largest healthcare systems recently invested $51 million to ...
Breaking Medicine News(10 mins):